Aterian Q2 2024 GAAP EPS $(0.52) Beats $(0.64) Estimate, Sales $27.984M Beat $23.945M Estimate
Portfolio Pulse from Benzinga Newsdesk
Aterian (NASDAQ:ATER) reported Q2 2024 GAAP EPS of $(0.52), beating the analyst estimate of $(0.64). Sales were $27.984M, surpassing the $23.945M estimate. However, sales decreased by 20.64% compared to the same period last year.
August 08, 2024 | 10:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aterian's Q2 2024 earnings and sales both beat analyst estimates, but sales are down 20.64% year-over-year.
Aterian's better-than-expected EPS and sales figures are positive short-term indicators, likely boosting investor confidence. However, the significant year-over-year sales decline may temper enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100